The effects of flavonoids in cardiovascular diseases

L Ciumărnean, MV Milaciu, O Runcan, ȘC Vesa… - Molecules, 2020 - mdpi.com
Flavonoids are metabolites of plants and fungus. Flavonoid research has been paid special
attention to in recent times after the observation of their beneficial effects on the …

Flavonoids in hypertension: a brief review of the underlying mechanisms

D Maaliki, AA Shaito, G Pintus, A El-Yazbi… - Current opinion in …, 2019 - Elsevier
Highlights•Increased flavonoid consumption imparts antihypertensive benefits.•Luteolin,
Quercetin, Kaempferol, Epicatechin, and Daidzein increase eNOS activity.•Many flavonoids …

Plant polyphenols and their potential benefits on cardiovascular health: A review

I Iqbal, P Wilairatana, F Saqib, B Nasir, M Wahid… - Molecules, 2023 - mdpi.com
Fruits, vegetables, and other food items contain phytochemicals or secondary metabolites
which may be considered non-essential nutrients but have medicinal importance. These …

Flavonoids in treatment of chronic kidney disease

YL Cao, JH Lin, HP Hammes, C Zhang - Molecules, 2022 - mdpi.com
Chronic kidney disease (CKD) is a progressive systemic disease, which changes the
function and structure of the kidneys irreversibly over months or years. The final common …

[PDF][PDF] Membangun Sinergi antar Perguruan Tinggi dan Industri Pertanian dalam Rangka Implementasi Merdeka Belajar Kampus Merdeka

MNUR ARIFIN, HAA ADINUGRAHA, B BASUKI… - 2021 - eprints.upnyk.ac.id
Penelitian ini bertujuan untuk mengetahui pengaruh daerah asal daerah tanaman sukun
dan ukuran panjang stek batang terhadap tingkat keberhasilan tumbuh stek batang sukun di …

Bioactive compounds and nanodelivery perspectives for treatment of cardiovascular diseases

RK Sindhu, A Goyal, E Algın Yapar, S Cavalu - Applied Sciences, 2021 - mdpi.com
Bioactive compounds are comprised of small quantities of extra nutritional constituents
providing both health benefits and enhanced nutritional value, based on their ability to …

Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and …

YC Lin, JW Lin, MS Wu, KC Chen, CC Peng, YN Kang - PloS one, 2017 - journals.plos.org
Background Calcium channel blocker (CCB) or two renin angiotensin aldosterone system
blockades (RAAS), angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin …

Flavonoids: Antioxidant Powerhouses and Their Role in Nanomedicine

M Zahra, H Abrahamse, BP George - Antioxidants, 2024 - pmc.ncbi.nlm.nih.gov
This study emphasizes the critical role of antioxidants in protecting human health by
counteracting the detrimental effects of oxidative stress induced by free radicals …

N-/T-Type vs. L-Type calcium channel blocker in treating chronic kidney disease: A systematic review and meta-analysis

M Zhao, Z Zhang, Z Pan, S Ma, M Chang, J Fan, S Xue… - Pharmaceuticals, 2023 - mdpi.com
Renin-angiotensin system (RAS) inhibitors and calcium channel blockers (CCB) are often
used together in chronic kidney disease (CKD). The PubMed, EMBASE, and Cochrane …

Clinical roles of calcium channel blockers in ischemic heart diseases

D Sueta, N Tabata, S Hokimoto - Hypertension Research, 2017 - nature.com
Abstract Calcium (Ca) channel blockers (CCBs) inhibit Ca 2+ channels in the myocardium or
vascular smooth muscle cells, inhibit myocardium contraction, inhibit the impulse conduction …